Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sreejesh Sreedharanu"'
Autor:
Minu Singh, Pankaj Sharma, Prateek Bhatia, Amita Trehan, Rozy Thakur, Sreejesh Sreedharanunni
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Introduction T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with poor prognosis and inferior outcome. Although multiple studies have been perform on genomics of T-ALL, data from Indian sub-continent is sca
Externí odkaz:
https://doaj.org/article/d610686b1dc04a3ba53460c3e4705f7a
Autor:
Pankaj Sharma, Parminder kaur, Prateek Bhatia, Amita Trehan, Sreejesh Sreedharanunni, Minu Singh
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Introduction Pediatric T-cell acute lymphoblastic leukemia (T-ALL) poses significant challenges due to its aggressive nature and resistance to standard treatments. Long non-coding RNAs (lncRNAs) have emerged as potential biomarkers and thera
Externí odkaz:
https://doaj.org/article/ddecabcf2c50444a82aaed04fb83e32f
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 3, Pp 204-205 (2023)
Externí odkaz:
https://doaj.org/article/a655d28af387492a9e4f77542dccd317
Autor:
Sanjeev Kumar Gupta, Minu Singh, Pragna H. Chandrashekar, Sameer Bakhshi, Amita Trehan, Ritu Gupta, Rozy Thakur, Smeeta Gajendra, Preity Sharma, Sreejesh Sreedharanunni, Manupdesh S. Sachdeva, Deepam Pushpam, Neelam Varma, Deepak Bansal, Richa Jain, Srinivasan Peyam, Anthony V. Moorman, Prateek Bhatia
Publikováno v:
HemaSphere, Vol 6, Iss 10, p e782 (2022)
Copy number alteration (CNA) status and CNA risk profiles of IKZF1plus, UK-ALL CNA risk groups and MRplus scores, were evaluated for clinical and prognostic impact in a cohort of 493 B-cell acute lymphoblastic leukemia cases diagnosed and treated und
Externí odkaz:
https://doaj.org/article/b950bc5a01cc428cb83e1fab0526250c
Autor:
Pandiarajan Vignesh, Gummadi Anjani, Rajni Kumrah, Ankita Singh, Sanjib Mondal, Johnson Nameirakpam, Ankur Jindal, Deepti Suri, Madhubala Sharma, Gurjit Kaur, Sathish Sharma, Kirti Gupta, Sreejesh Sreedharanunni, Amit Rawat, Surjit Singh
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundHemophagocytic lymphohistiocytosis (HLH) is characterized by uncontrolled and excessive inflammation leading to high mortality. Aetiology of HLH can be primarily due to genetic causes or secondarily due to infections or rheumatological illn
Externí odkaz:
https://doaj.org/article/394ded5ac64e4d969a75dcbb91a71fae
Autor:
Vijai Williams, Nisha Menon, Prateek Bhatia, Manisha Biswal, Sreejesh Sreedharanunni, Muralidharan Jayashree, Karthi Nallasamy
Publikováno v:
Tropical Medicine and Health, Vol 49, Iss 1, Pp 1-8 (2021)
Abstract Background Hyperferritinemia is increasingly associated with mortality in sepsis. Studies estimating the prevalence of hyperferritinemia in pediatric scrub typhus are limited. Methods This was a secondary analysis of a prospective observatio
Externí odkaz:
https://doaj.org/article/131343a40a21445ba948bac2f20a1072
Autor:
Aaqib Z Banday, Dharmagat Bhattarai, Naveen Bhagat, Sreejesh Sreedharanunni, Sumeeta Khurana, Deepti Suri
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 10, Iss 9, Pp 3511-3514 (2021)
Evaluation of pediatric hypereosinophilia (HE) is challenging, especially in the tropical developing countries, as appropriate diagnostic facilities may be lacking, parasitic/helminthic infections are common, and existing data on the etiology of seve
Externí odkaz:
https://doaj.org/article/7ada4eb3e4474c5b93b334d858dfd5e6
Autor:
V. Tejaswi, Deepesh P. Lad, Nishant Jindal, Gaurav Prakash, Pankaj Malhotra, Alka Khadwal, Arihant Jain, Sreejesh Sreedharanunni, Manupdesh Singh Sachdeva, Shano Naseem, Neelam Varma, Subhash Varma
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 866-872 (2020)
PURPOSE Chronic lymphocytic leukemia (CLL) is uncommon in India. There are limited studies on CLL from the Indian subcontinent. METHODS This was a prospective study (2011-2017) of consecutively diagnosed patients with CLL at a single center. The diag
Externí odkaz:
https://doaj.org/article/8f9fd2b95af74cf5b97c11ead5a1dd2e
Autor:
Rozy Thakur, Prateek Bhatia, Minu Singh, Sreejesh Sreedharanunni, Pankaj Sharma, Aditya Singh, Amita Trehan
Publikováno v:
Diagnostics, Vol 13, Iss 5, p 884 (2023)
Methods: Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse) and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the non-relapse arm, were retrieved from the biobank for advanced genomic
Externí odkaz:
https://doaj.org/article/c474539d64ad41f09cd093b1c556789b
Autor:
Liza Das, Nidhi Gupta, Pinaki Dutta, Rama Walia, Kim Vaiphei, Ashutosh Rai, Bishan Dass Radotra, Kirti Gupta, Sreejesh Sreedharanunni, Chirag Kamal Ahuja, Anil Bhansali, Manjul Tripathi, Ridhi Sood, Sivashanmugam Dhandapani
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
IntroductionAggressive pituitary adenomas (APAs) are, by definition, resistant to optimal multimodality therapy. The challenge lies in their early recognition and timely management. Temozolomide is increasingly being used in patients with APAs, but e
Externí odkaz:
https://doaj.org/article/5dc64f2960db46f3973ffa5da16e92d8